Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PI 620

Known as: PI-620, PI620 cpd 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrimidinesThiophenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
The phosphatidylinositide 3-kinase pathway is frequently deregulated in human cancers and inhibitors offer considerable… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Pharmacological properties of the PI3 kinase (PI3K) inhibitors PI-540 and PI-620
AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA LB-149 The PI3K pathway is highly deregulated in cancer and has been the… Expand
Is this relevant?
2008
2008
The novel potent PI3 Kinase inhibitors, PI-540 and PI-620: Activity in vitro and in vivo
AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA LB-192 Phosphatidylinositol-3-kinases (PI3K) are lipid kinases that… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE